Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Consumer products · CIK 0000021076
$88.66
+4.59% · delayed ~15 min
Last price from Oct 22, 2026
$10.88B market value
From CLOROX CO /DE/'s FY2025 10-K, filed Aug 8, 2025 · read the filing
CLOROX /DE/ makes soap, cleaning and personal care products. It took in $7.10B last year, which makes it a mid-sized company. Of every dollar it sells, about 11 cents is left as profit.
The financial picture is led by profitability, debt and accounting, with growth worth watching.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
Strong finances across the board.
From CLOROX CO /DE/'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Profit
$280.0M → $810.0M
Free cash flow
$483.0M → $761.0M
Earnings per share
$2.25 → $6.60
Profit margin
3.9% → 11.4%
Measured against FY2024, from the 10-K filed Aug 8, 2025
Improved: +189.3%
$280.0M to $810.0MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
How the latest move compares (quote delayed ~15 min), and what was published around it
CLX rose 4.59% on the latest quote. The average Consumer Staples company tracked here moved +4.03%, and the S&P 500 −1.04%. That is 0.6 points above its sector and 5.6 points above the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 4% a year for the next 10 years. Over the last 10 years it grew by about 0% a year.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 11 cents of every dollar of sales as profit, earning $810.0M last year.
Barely. Sales were roughly flat, up 0.2%.
No. At its current cash flow it could clear its debt in about 2.4 years. For every $1 it owes, it owns $1.09 in assets.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 74 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It paid out 61% of the cash its operations generated. It has paid in each of the last 12 years.
GoodFigures from the FY2025 annual filing
Last year it earned $810.0M and generated $981.0M of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Aug 8, 2025Filing for FY2025 | FY202410-K · Aug 8, 2024Filing for FY2024 | FY202310-K · Aug 10, 2023Filing for FY2023 | FY202210-K · Aug 10, 2022Filing for FY2022 | FY202110-K · Aug 10, 2021Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $7.10B | $7.09B | $7.39B | $7.11B | $7.34B | +0.2% |
| Cost of revenue | $3.89B | $4.04B | $4.48B | $4.56B | $4.14B | −3.8% |
| Gross profit | $3.21B | $3.05B | $2.91B | $2.54B | $3.20B | +5.4% |
| Gross marginGross profit ÷ revenueWhat is this? | 45.2% | 43.0% | 39.4% | 35.8% | 43.6% | +2.3 pts |
| Selling, general and administrative | $1.12B | $1.17B | $1.18B | $954.0M | $1.00B | −3.7% |
| Interest expense | $88.0M | $90.0M | $90.0M | $106.0M | $99.0M | −2.2% |
| Income before tax | $1.08B | $398.0M | $238.0M | $607.0M | $900.0M | +170.9% |
| Net income | $810.0M | $280.0M | $149.0M | $462.0M | $710.0M | +189.3% |
| Net marginNet income ÷ revenueWhat is this? | 11.4% | 3.9% | 2.0% | 6.5% | 9.7% | +7.5 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $6.60 | $2.25 | $1.20 | $3.75 | $5.78 | +192.8% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| CLXCLOROX CO /DE/ · this page | 9.0/10 | 7/9 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Had shares withheld to cover taxes — 1,106 shares at $80.41 ($88.9K)
Holds 36,179 shares after this filing.
Was granted or awarded shares — 1,677 shares at $80.41 ($134.8K)
Holds 76,471 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Proxy statement for a shareholder meeting
Read the filingAnnual report on Form 10-K
Read the filingWrite down why you are following CLOROX CO /DE/, what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 108 subsidiaries named in its 10-K, incorporated across 47 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from CLX's 10-K for fiscal year 2025 (period ending 2025-06-30, filed Aug 8, 2025), reported under the US GAAP taxonomy. View the source filing.
4 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. All four had enough reported figures. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 9 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 9.0 | 7/9 | 10-K, filed Aug 8, 2025 |
| FY2024 | 6.0 | 7/9 | 10-K, filed Aug 8, 2024 |
| FY2023 | 8.0 | 6/9 | 10-K, filed Aug 10, 2023 |
| FY2022 | 7.0 | 5/9 | 10-K, filed Aug 10, 2022 |
| FY2021 | 8.0 | 6/9 | 10-K, filed Aug 10, 2021 |
| FY2020 | 9.0 | 7/9 | 10-K, filed Aug 13, 2020 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
7 of 9 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's.
3.30
In the safe zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
-2.52
Below the threshold — nothing unusual flagged
Scores above -1.78 are the ones the model associates with earnings manipulation.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +57.6%
$483.0M to $761.0MCritical
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Improved: +192.8%
$2.25 to $6.60Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +7.4 pts
3.9% to 11.4%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -17.3%
$202.0M to $167.0MSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +5.4%
$3.05B to $3.21BNotable
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +2.3 pts
43.0% to 45.2%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: -1.2%
124.2M to 122.7MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q3 FY2026 against Q3 FY2025, from the 10-Q filed Apr 30, 2026 — read it.
Improved: +425.2%
$226.0M to $1.19BCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: −1.4 pts
44.6% to 43.2%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: -1.9%
123.3M to 120.9MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q3 FY2026 against Q2 FY2026, from the 10-Q filed Apr 30, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +422.9%
$227.0M to $1.19BCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +19.1%
$157.0M to $187.0MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +19.1%
$1.30 to $1.55Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +1.8 pts
9.4% to 11.2%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
4 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 2% and 6%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Opinions from 27 analysts covering this company, as of . Their views, not this site's.
Of 27 analysts publishing on this company, 1 say strong buy, 17 say hold, 8 say sell and 1 say strong sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 9.4% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 17.8x — investors pay $17.8 for each $1 of trailing profit.
Nothing unusual. Its accounting patterns look like those of companies that report earnings straightforwardly.
| 0.2% |
| 11.4% |
| 13.43x |
| 15.82x |
| PGPROCTER & GAMBLE Co | 9.0/10 | 7/9 | 3.3% | 18.4% | 23.99x | 1.33x |
|---|
| CLCOLGATE PALMOLIVE CO | 9.0/10 | 5/9 | 1.4% | 10.5% | 36.60x | 295.65x |
|---|
| KMBKIMBERLY CLARK CORP | 7.3/10 | 5/9 | -2.1% | 12.3% | 18.45x | 10.38x |
|---|
| CHDCHURCH & DWIGHT CO INC /DE/ | 9.0/10 | 7/9 | 1.6% | 11.9% | 36.34x | 1.23x |
|---|
| Median of peers | 9.0/10 | — | 1.5% | 12.1% | 30.16x | 5.86x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Had shares withheld to cover taxes — 580 shares at $80.41 ($46.6K)
Holds 75,891 shares after this filing.
Had shares withheld to cover taxes — 1,031 shares at $80.41 ($82.9K)
Holds 74,860 shares after this filing.
Was granted or awarded shares — 6,637 shares at $80.41 ($533.7K)
Holds 74,414 shares after this filing.
Had shares withheld to cover taxes — 2,296 shares at $80.41 ($184.6K)
Holds 72,118 shares after this filing.
Had shares withheld to cover taxes — 2,351 shares at $80.41 ($189.0K)
Holds 69,767 shares after this filing.
Was granted or awarded shares — 4,191 shares at $80.41 ($337.0K)
Holds 94,618 shares after this filing.
Had shares withheld to cover taxes — 100 shares at $80.41 ($8.0K)
Holds 94,518 shares after this filing.
Had shares withheld to cover taxes — 1,532 shares at $80.41 ($123.2K)
Holds 92,986 shares after this filing.
Was granted or awarded shares — 6,637 shares at $80.41 ($533.7K)
Holds 83,591 shares after this filing.
Had shares withheld to cover taxes — 1,951 shares at $80.41 ($156.9K)
Holds 81,640 shares after this filing.
Had shares withheld to cover taxes — 2,142 shares at $80.41 ($172.2K)
Holds 79,498 shares after this filing.
Was granted or awarded shares — 1,172 shares at $80.41 ($94.2K)
Holds 10,386 shares after this filing.
Had shares withheld to cover taxes — 30 shares at $80.41 ($2.4K)
Holds 10,356 shares after this filing.
Had shares withheld to cover taxes — 339 shares at $80.41 ($27.3K)
Holds 10,017 shares after this filing.
Was granted or awarded shares — 29,352 shares at $80.41 ($2.4M)
Holds 282,488 shares after this filing.
Had shares withheld to cover taxes — 692 shares at $80.41 ($55.6K)
Holds 281,796 shares after this filing.
Had shares withheld to cover taxes — 11,989 shares at $80.41 ($964.0K)
Holds 269,807 shares after this filing.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Published results · Made a Regulation FD disclosure
Had a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingReported another event
Read the filingQuarterly report for Q3 FY2026
Cash +425.2% · Gross margin −1.4 pts · Shares in issue -1.9% — against Q3 FY2025
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingMade a Regulation FD disclosure · Reported another event
Read the filingSigned a material agreement · Took on a direct financial obligation
Read the filingQuarterly report for Q2 FY2026
Profit margin −2.1 pts · Profit -18.7% · Earnings per share -17.1% — against Q2 FY2025
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingMade a Regulation FD disclosure · Reported another event
Read the filingHeld a shareholder vote
Read the filingQuarterly report for Q1 FY2026
Revenue -18.9% · Free cash flow -68.7% · Cash -40.3% — against Q1 FY2025
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingHad a director or senior officer leave or join
Read the filingProxy statement for a shareholder meeting
Read the filingAnnual report for FY2025
Profit margin +7.4 pts · Profit +189.3% · Free cash flow +57.6% — against FY2024
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingThe first 40 of 108. The rest are in the exhibit.
Source: Exhibit 21 of the 10-K filed 2026-08-07. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
S&P 500 Top Movers: Oct. 21, 2026 US Session
ChartMill ·
Kimberly-Clark vs. Clorox: The Higher Yield May Not Be the Better Dividend
Yahoo ·
S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Losers
ChartMill ·
4 Top Dividend Stocks Yielding 4% or More to Buy Right Now for Passive Income
Yahoo ·
Clorox vs. Colgate: One Pays Nearly 6%, but Is It a Dividend Trap?
Yahoo ·
Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
Benzinga ·
Kimberly-Clark vs. Clorox: Which Dividend Stock Pays You More in 10 Years?
Yahoo ·
JP Morgan Maintains Underweight on Clorox, Lowers Price Target to $83
Benzinga ·
October's 5 Dividend Growth Stocks With Yields Up To 7.99%
SeekingAlpha ·
Better Dividend Stock for Retirees: Clorox vs. J.M. Smucker
Yahoo ·
S&P 500 Gap-Down Stocks in Today's Session
ChartMill ·
Procter & Gamble's Innovation Push: Catalyst for Long-Term Growth?
Yahoo ·
Primary sources and further research